Oxidized LDL Triggers Pro-Oncogenic Signaling in Human Breast Mammary Epithelial Cells Partly via Stimulation of MiR-21

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Khaidakov, Magomed ^a   Mehta, Jawahar L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CXCL16 CHEMOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOXYGENASE; LIPOXYGENASE 12; LIPOXYGENASE 15; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN MSR1; PROTEIN P22; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER RECEPTOR; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST EPITHELIUM; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOCHONDRION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

CELL LINE; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS, LDL; MAMMARY GLANDS, HUMAN; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASES; NADPH OXIDASE; NF-KAPPA B; ONCOGENE PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, SCAVENGER; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 84867589201     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046973     Document Type: Article

References (50)

1. Cleary MP, Grossmann ME, Ray A, (2010) Effect of obesity on breast cancer development. Vet Pathol 47: 202-213.
2. Romieu I, Lajous M, (2009) The role of obesity, physical activity and dietary factors on the risk for breast cancer: Mexican experience. Salud Publica Mex 51 Suppl 2: s172-180.
3. Kelesidis, Kelesidis T, Mantzoros CS, (2006) Adiponectin and cancer: a systematic review. Brit J Cancer 94: 1221-1225.
4. Calle EE, Thun MJ, (2004) Obesity and Cancer. Oncogene 23: 6365-6378.
5. Lorincz AM, Sukumar S, (2006) Molecular links between obesity and breast cancer. Endocr Relat Cancer 13: 279-292.
6. Mehta JL, (2004) The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein in atherosclerosis. Can J Cardiol Suppl B pp. 32B-36B.
7. Vohra RS, Murphy JE, Walker JH, Ponnambalam S, Homer-Vanniasinkam S, (2006) Atherosclerosis and the Lectin-like OXidized low-density lipoprotein scavenger receptor. Trends Cardiovasc Med 16: 60-64.
8. Sawamura T, Kume N, Aoyama T, (1997) An endothelial receptor for oxidized low-density lipoprotein. Nature 386: 73-77.
9. Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, et al. (2008) The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J 409: 349-355.
10. Heinloth A, Heermeier K, Raff U, Wanner C, Gallr J, (2000) Stimulation of NADPH Oxidase by Oxidized Low-Density Lipoprotein Induces Proliferation of Human Vascular Endothelial Cells. J Am Soc Nephrol 200, 11: 1819-1825.
11. Wadsack C, Hirschmugl B, Hammer A, Levak-Frank S, Kozarsky KF, et al. (2003) Scavenger receptor class B, type I on non-malignant and malignant human epithelial cells mediates cholesteryl ester-uptake from high density lipoproteins. Int J Biochem Cell Biol 35: 441-454.
12. Monks J, Rosner D, Jon Geske F, Lehman L, Hanson L, et al. (2005) Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ 12: 107-114.
13. Hirsch HA, Iliopoulos D, Joshi A, Zhang Y, Jaeger S, et al. (2010) Transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell 17: 348-361.
14. Khaidakov M, Mitra S, Kadlubar S, Novelli G, Raj V, et al. (2011) Oxidized LDL receptor 1 (LOX-1) as a possible link between obesity and cancer. PLoS ONE 6 (5) (): e20277 doi:10.1371/journal.pone.0020277.
15. Wang X, Spandidos A, Wang H, Seed B, (2012) PrimerBank: a PCR primer database for quantitative gene expression analysis.Nucl. Acids Res 40 (D1) (): D1144-1149.
16. Takahashi Y, Zhu H, Yoshimoto T, (2005) Essential roles of lipoxygenases in LDL oxidation and development of atherosclerosis. Antioxid Redox Signal 7: 425-431.
17. Dandapat A, Hu C, Sun L, Mehta JL, (2007) Small concentrations of ox-LDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler Thromb Vasc Biol 27: 2435-2442.
18. Brinkley TE, Kume N, Mitsuoka H, Phares DA, Hagberg JM, (2008) Elevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal women. Obesity (Silver Spring) 16: 1454-1456.
19. Park SH, Kim JY, Lee JH, Park HY, (2011) Elevated oxidized low-density lipoprotein concentrations in postmenopausal women with the metabolic syndrome. Clin Chim Acta 412: 435-440.
20. Bae YS, Lee JH, Choi SH, Kim S, Almazan F, et al. (2009) Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res 104: 210-8.
21. Chow SE, Hshu YC, Wang JS, Chen JK, (2007) Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages. J Appl Physiol 102: 1520-1527.
22. Singh SP, Chen T, Chen L, Mei N, McLain E, et al. (2005) Mutagenic effects of 4-hydroxynonenal triacetate, a chemically protected form of the lipid peroxidation product 4-hydroxynonenal, as assayed in L5178Y/Tk+/- mouse lymphoma cells. J Pharmacol Exp Ther 313: 855-861.
23. Salzman R, Pácal L, Tomandl J, Kanková K, Tóthová E, et al. (2009) Elevated malondialdehyde correlates with the extent of primary tumor and predicts poor prognosis of oropharyngeal cancer. Anticancer Res 29: 4227-4231.
24. Takahashi Y, Zhu H, Yoshimoto T, (2005) Essential roles of lipoxygenases in LDL oxidation and development of atherosclerosis. Antioxid Redox Signal 7: 425-431.
25. Parthasarathy S, Wieland E, Steinberg D, (1989) A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci U S A 86: 1046-1050.
26. Rankin SM, Parthasarathy S, Steinberg DJ, (1991) Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. Lipid Res 324: 449-56.
27. Guo AM, Liu X, Al-Wahab Z, Maddippati KR, Ali-Fehmi R, et al. (2011) Role of 12-lipoxygenase in regulation of ovarian cancer cell proliferation and survival. Cancer Chemother Pharmacol 68: 1273-1283.
28. Yin B, Yang Y, Zhao Z, Zeng Y, Mooney SM, et al. (2011) Arachidonate 12-lipoxygenase may serve as a potential marker and therapeutic target for prostate cancer stem cells. Int J Oncol 38: 1041-1046.
29. Natarajan R, Esworthy R, Bai W, Gu JL, Wilczynski S, et al. (1997) Increased 12-lipoxygenase expression in breast cancer tissues and cells. Regulation by Epidermal Growth Factor. J. Clin. Endocrinol. Metab 82: 1790-1798.
30. Connolly JM, Rose DP, (1998) Enhanced angiogenesis and growth of 12-lipoxygenase gene-transfected MCF-7 human breast cancer cells in athymic nude mice. Cancer Lett 132: 107-112.
31. Piao YS, Du YC, Oshima H, Jin JC, Nomura M, et al. (2008) Platelet-type 12-lipoxygenase accelerates tumor promotion of mouse epidermal cells through enhancement of cloning efficiency. Carcinogenesis 29: 440-447.
32. Tong WG, Ding XZ, Adrian TE, (2002) The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem Biophys Res Comm 296: 942-948.
33. Zuo X, Shureiqi I, (2011) 15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in? Cancer Metastasis Rev 30: 481-491.
34. Fürstenberger G, Krieg P, Müller-Decker K, Habenicht AJ, (2006) What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int J Cancer 119: 2247-2254.
35. Yoshinaga M, Buchanan FG, DuBois RN, (2004) 15-LOX-1 inhibits p21 (Cip/WAF 1) expression by enhancing MEK-ERK 1/2 signaling in colon carcinoma cells. Prostaglandins Other Lipid Mediat 73: 111-122.
36. Nixon JB, Kim KS, Lamb PW, Bottone FG, Eling TE, (2004) 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer. Prostaglandins Leukot Essent Fatty Acids 70: 7-15.
37. Shureiqi I, Wojno KJ, Poore JA, Reddy RG, Moussalli MJ, et al. (1999) Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis 20: 1985-1895.
38. Tang S, Bhatia B, Maldonado CJ, Yang P, Newman RA, et al. (2002) Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J Biol Chem 277: 16189-16201.
39. Yu S, Wong SL, Lau CW, Huang Y, Yu CM, (2011) Oxidized LDL at low concentration promotes in-vitro angiogenesis and activates nitric oxide synthase through PI3K/Akt/eNOS pathway in human coronary artery endothelial cells. Biochem Biophys Res Commun 407: 44-48.
40. Wang WY, Li J, Yang D, Xu W, Zha RP, et al. (2010) OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways. Cardiovasc Res 85: 845-852.
41. Li M, Lin J, Wang Z, He S, Ma X, et al. (2010) Oxidized low-density lipoprotein-induced proinflammatory cytokine response in macrophages are suppressed by CD4CD25(+)Foxp3(+) regulatory T cells through downregulating toll like receptor 2-mediated activation of NF-kappaB. Cell Physiol Biochem 25: 649-656.
42. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417: 949-954.
43. Garnett MJ, Marais R, (2004) Guilty as charged; B-RAF is a human oncogene. Cancer Cell 6: 313-319.
44. Schubbert S, Shannon K, Bollag G, (2007) Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 7: 295-308.
45. Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, et al. (2001) Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells. Mol Endocrinol 15: 1344-1359.
46. Bonci D, (2010) MicroRNA-21 as therapeutic target in cancer and cardiovascular disease. Recent Pat Cardiovasc Drug Discov 5: 156-161.
47. Si ML, Zhu S, Wu H, Lu Z, Wu F, et al. (2007) miR-21-mediated tumor growth. Oncogene 26: 2799-2803.
48. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, et al. (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14: 2348-2360.
49. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
50. Medina PP, Nolde M, Slack FJ, (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467: 86-90.